akampion.com

:: akampion :: we create visibility

Please click here to subscribe to regular news updates from the akampioneer.com. Tuesday, May 12, 2015. Company News: New Peer-Reviewed Publication Provides Further Insights into Mechanism of ISA Pharmaceuticals’ SLP Immunotherapeutics. SLP s modulate intratumoral macrophages required for tumor regression. ISA Pharmaceuticals B.V. Monday, May 11, 2015. Company News: Curetis Strengthens Executive Team; Appoints Dr. Achim Plum as Chief Commercial Officer. A developer of next-level molecular diagnostic solu...

http://www.akampion.com/

OVERVIEW OF akampion.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

7

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR AKAMPION.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.6 out of 5 with 14 reviews

5 star

4

4 star

5

3 star

3

2 star

0

1 star

2

Hey there! Start your review of akampion.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

1.3 seconds

CONTACTS AT AKAMPION.COM

Akampion

Ines-Regina Buth

Wilhelms●●●●●●●● Str. 34

Be●●in , 10551

DE

49.3●●●●2768

in●●@akampion.com

View this contact

Akampion

Ines-Regina Buth

Wilhelms●●●●●●●● Str. 34

Be●●in , 10551

DE

49.3●●●●2768

in●●@akampion.com

View this contact

1&1 Internet AG

Hostmaster EINSUNDEINS

Brau●●●●. 48

Kar●●●uhe , 76135

DE

49.●●●600

49.72●●●●●74248

ho●●●●●●●●@1und1.de

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2006 March 13
UPDATED: 2014 March 14
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

18

YEARS
2

MONTHS
8

DAYS

NAME SERVERS

1: ns55.1und1.de
2: ns56.1und1.de

REGISTRAR

1 & 1 INTERNET AG

WHOIS : whois.schlund.info

REFERRED : http://1and1.com

CONTENT

PAGES IN
THIS WEBSITE

7

SSL

EXTERNAL LINKS

37

SITE IP

82.165.209.215

LOAD TIME

1.283 sec

SCORE

6.2

PAGE TITLE

:: akampion :: we create visibility | akampion.com Reviews

<META> DESCRIPTION

Please click here to subscribe to regular news updates from the akampioneer.com. Tuesday, May 12, 2015. Company News: New Peer-Reviewed Publication Provides Further Insights into Mechanism of ISA Pharmaceuticals’ SLP Immunotherapeutics. SLP s modulate intratumoral macrophages required for tumor regression. ISA Pharmaceuticals B.V. Monday, May 11, 2015. Company News: Curetis Strengthens Executive Team; Appoints Dr. Achim Plum as Chief Commercial Officer. A developer of next-level molecular diagnostic solu...

<META> KEYWORDS

1 Corporate Communications

2 Reputation Management

3 Consulting

4 Strategy

5 Investor Relations

6 Public Relations

7 Branding

8 Media Relations

9 Networking

10 Visibility

CONTENT

Page content here

KEYWORDS ON PAGE

akampion news,curetis ag,disclaimer

SERVER

Apache

POWERED BY

PHP/5.5.24

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

:: akampion :: we create visibility | akampion.com Reviews

https://akampion.com

Please click here to subscribe to regular news updates from the akampioneer.com. Tuesday, May 12, 2015. Company News: New Peer-Reviewed Publication Provides Further Insights into Mechanism of ISA Pharmaceuticals’ SLP Immunotherapeutics. SLP s modulate intratumoral macrophages required for tumor regression. ISA Pharmaceuticals B.V. Monday, May 11, 2015. Company News: Curetis Strengthens Executive Team; Appoints Dr. Achim Plum as Chief Commercial Officer. A developer of next-level molecular diagnostic solu...

INTERNAL PAGES

akampion.com

1

:: akampion :: we create visibility

http://www.akampion.com/approach.php

The core of our work is a strong enthusiasm for innovation-driven companies, novel products and technologies. Innovation leaders need a more pronounced profile in the public perception. Therefore, we are dedicated to making the benefits of innovation tangible for example when it comes to promising treatments for life-threatening diseases or improving the quality of our daily life. Our Triple C approach. Subscribe to news updates. Follow us on twitter.

2

:: akampion :: we create visibility

http://www.akampion.com/index.php

Please click here to subscribe to regular news updates from the akampioneer.com. Friday, August 19, 2016. Company News: Curetis Reports Financial Results for the First Six Months of 2016. Key business and commercial milestones and goals met. Global presence further strengthened with subsidiaries in the U.S., UK, France and the Netherlands. The “ Company. 8221; and, together with Curetis GmbH, “ Curetis. Operational and Business Highlights 2016 to Date. Tuesday, August 16, 2016. The accreditation comes fr...

3

:: akampion :: we create visibility

http://www.akampion.com/imprint.php

Lübecker Str. 28. 10559 Berlin, Germany. Tel: 49 (0)30 2363 2768. Dr Ludger Weß. 22587 Hamburg, Germany. Tel: 49 (0)40 8816 5964. Editorial: Ines-Regina Buth, Dr. Ludger Weß. E-Mail: info(at)akampion.com. Design and Programming: Design Direction. Subscribe to news updates. Follow us on twitter.

4

:: akampion :: we create visibility

http://www.akampion.com/akampion.php

Telling your company s story is not an easy job - but it is crucial for reaching your corporate goals. Wouldn t it be great to find a committed partner to define and convey your story in a powerful way? Someone who provides you with a fresh, un-biased perspective and successfully connects you to corporate partners, the media and the investment community? And Head of Investor Relations at Micromet. Subscribe to news updates. Follow us on twitter.

5

:: akampion :: we create visibility

http://www.akampion.com/disclaimer.php

Contents of the web site. Links to third party information. The akampion web site links to third party information providers. Ines-Regina Buth and Ludger Wess have no influence on the contents or reliability of the web sites of these third party information providers. The following therefore applies to all links:. The declaration is valid for all links given on our web site and the material of all sites reached via banners and links on the akampion web site. Subscribe to news updates. Follow us on twitter.

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL PAGES IN THIS WEBSITE

7

LINKS TO THIS WEBSITE

akampioneer.com

Akampion Meets… | the akampioneer

http://akampioneer.com/category/akampion-meets

Season s Greetings from akampion. Friday, December 18, 2015. Dear friends and colleagues,. As 2015 is coming to a close, we would like to take the opportunity to thank you for your continued support and wish you a relaxed, peaceful Christmas holiday and a Happy New Year! Our highlights in 2015 include Read more. The continued expansion of akampion s client base,. Strengthened strategic partnerships with colleagues in the U.S. to ensure optimum transatlantic communication programs for our clients,. If you...

akampioneer.com

Food For Thought | the akampioneer

http://akampioneer.com/category/food-for-thought

Food for Thought: How to (Not? Create a Buzz With Your Corporate Press Release. Wednesday, May 30, 2012. This week, NYC-base d. Immune Response BioPharma, Inc. Announced that the company has terminated partnering discussions on its multiple sclerosis vaccine NeuroVax with GlaxoSmithKline. The news. Per se may not trigger a lot of interest – but the company has managed to create a significant buzz around its announcement, with CEO David Buswell stating that (quote from corporate press release):. Food for ...

akampioneer.com

ISA Pharmaceuticals Announces Start of First Phase I/II Clinical Trial of its SLP®-AMPLIVANT® Conjugates | the akampioneer

http://akampioneer.com/company-news/company-news-isa-pharmaceuticals-announces-start-of-first-phase-iii-clinical-trial-of-its-slp®-amplivant®-conjugates.html

Company News: ISA Pharmaceuticals Announces Start of First Phase I/II Clinical Trial of its SLP -AMPLIVANT Conjugates. Thursday, February 26, 2015. Leiden University Medical Center to study novel immunotherapeutic in HPV-positive head and neck cancer patients. ISA Pharmaceuticals B.V. S) covalently linked to AMPLIVANT. A synthetic Toll-like receptor (TLR) 1/2 ligand. The investigators have assigned the acronym HESPECTA to the conjugate (HPV E-Six Peptide Conjugated To AMPLIVANT. Conjugates have demonstra...

akampioneer.com

Anergis Presents Sustained Efficacy Data from its AllerT Phase IIb Trial at the AAAAI Annual Meeting | the akampioneer

http://akampioneer.com/company-news/company-news-anergis-presents-sustained-efficacy-data-from-its-allert-phase-iib-trial-at-the-aaaai-annual-meeting.html

Company News: Anergis Presents Sustained Efficacy Data from its AllerT Phase IIb Trial at the AAAAI Annual Meeting. Monday, February 23, 2015. Contiguous Overlapping Peptide allergy immunotherapeutic AllerT confirms sustained efficacy in the second year following treatment. A company developing novel and proprietary ultra-fast allergy immunotherapeutics, presented detailed data from the Phase IIb trial of its birch pollen allergy immunotherapeutic AllerT in two separate scientific posters at the AAAAI (.

akampioneer.com

Memberships | the akampioneer

http://akampioneer.com/memberships

We are members of:. DVFA Life Science Committee. Company News: Curetis Reports Financial Results for the First Six Months of 2016. Company News: Agena Bioscience Expands ISO Accreditation for Genetic Testing. Company News: Curetis to Report its Half-Year Results 2016 on August 19, 2016. Company News: New CELL Study presents groundbreaking pre-clinical work: developing immune therapy to potentially treat serious inf. Company News: Molecular Health Strengthens U.S. Based Executive Management Team. Company ...

akampioneer.com

Imprint | the akampioneer

http://akampioneer.com/imprint

Lübecker Str. 28. 10559 Berlin, Germany. Tel: 49 (0)30 2363 2768. 22587 Hamburg, Germany. Tel: 49 (0)40 8816 5964. Editorial: Ines-Regina Buth and Dr. Ludger Wess. Company News: Curetis Reports Financial Results for the First Six Months of 2016. Company News: Agena Bioscience Expands ISO Accreditation for Genetic Testing. Company News: Curetis to Report its Half-Year Results 2016 on August 19, 2016. Company News: Molecular Health Strengthens U.S. Based Executive Management Team. Company News: Curetis Ann...

akampioneer.com

Curetis Expands Commercial Organization | the akampioneer

http://akampioneer.com/company-news/company-news-curetis-expands-commercial-organization.html

Company News: Curetis Expands Commercial Organization. Monday, April 20, 2015. Augmented direct sales force, led by new Head of International Sales to broaden reach in key European markets. New distribution partnerships in Italy and Middle East. In addition to these platform and product enhancements, the Company is expanding its geographic scope, with an FDA trial underway in the U.S. and pre-commercial activities in Asia and other non-European countries. Posted in Company News. In vitro diagnostics (IVD).

akampioneer.com

Curetis Initiates Clinical CE Performance Evaluation of Unyvero P55 Pneumonia Application | the akampioneer

http://akampioneer.com/company-news/company-news-curetis-initiates-clinical-ce-performance-evaluation-of-unyvero-p55-pneumonia-application.html

Company News: Curetis Initiates Clinical CE Performance Evaluation of Unyvero P55 Pneumonia Application. Monday, March 9, 2015. Clinical study to test more than 400 patient samples. Follows successful completion of analytical CE Performance Evaluation in more than 400 cartridge runs. Expected results and product launch in spring 2015. The P55 Cartridge comes with a panel of up to 21 pathogens and up to 19 antibiotic resistance markers. Additions are expected to include e.g. Imp, ndm, vim. The new cartrid...

akampioneer.com

Curetis Strengthens Executive Team; Appoints Dr. Achim Plum as Chief Commercial Officer | the akampioneer

http://akampioneer.com/company-news/company-news-curetis-strengthens-executive-team-appoints-dr-achim-plum-as-chief-commercial-officer.html

Company News: Curetis Strengthens Executive Team; Appoints Dr. Achim Plum as Chief Commercial Officer. Monday, May 11, 2015. Former Siemens Healthcare manager adds broad expertise in molecular diagnostics, sales, marketing, and business development. Posted in Company News. Tags: and business development. In vitro diagnostics (IVD). You can follow any responses to this entry through the RSS 2.0. Both comments and pings are currently closed. Company News: New Peer-Reviewed Publication Provides Further Insi...

akampioneer.com

New Peer-Reviewed Publication Provides Further Insights into Mechanism of ISA Pharmaceuticals’ SLP® Immunotherapeutics | the akampioneer

http://akampioneer.com/company-news/company-news-new-peer-reviewed-publication-provides-further-insights-into-mechanism-of-isa-pharmaceuticals’-slp®-immunotherapeutics.html

Company News: New Peer-Reviewed Publication Provides Further Insights into Mechanism of ISA Pharmaceuticals’ SLP Immunotherapeutics. Tuesday, May 12, 2015. SLP s modulate intratumoral macrophages required for tumor regression. ISA Pharmaceuticals B.V. A clinical-stage immunotherapy company focusing on rationally designed immunotherapeutics against cancer and persistent viral infections, today announced the publication of a new peer-reviewed paper*. Based on these observations, the targeting of macrophage...

UPGRADE TO PREMIUM TO VIEW 27 MORE

TOTAL LINKS TO THIS WEBSITE

37

SOCIAL ENGAGEMENT

akampion

OTHER SITES

akamperman.nl

Timmer- en afbouwbedrijf A. Kamperman

akampharma.com

AkamPharma | Home

A Clear Vision Is Our Mission. Health also refers to the general wellness. A Clear Vision Is Our Mission. Akam Darou mission leads what we do. progressing focuses on Akam Darous Promoting, positive and targeted method as we look forward. Health shows a wide commitment to health services, supported by a large range of products that help improve the welfare state of patients around the country. health also refers to the general wellness of our customers, employees and communities. Middle income countries f...

akamphysics10.blogspot.com

MYP PHYSICS

This is our year 10 myp blog. We can use it to share our learning experiences. Sunday, June 3, 2012. How can physics improve car safety? Read the document (http:/ www.who.int/world-health-day/previous/2004/en/traffic facts en.pdf), WHO Road Traffic Injuries, below. State the problem/issue that physicists are able to address using this process. Explain how physics can be used to solve this problem. Explain any benefits and limitations of using this process. Assessment Criteria One World A. The student sta...

akamphyzics.blogspot.com

MYP PHYSICS

All science is either physics or stamp collecting -Lord Kelvin. Sunday, January 8, 2012. You are a travel company advertising trips into space to visit the planets in the solar system. Your task is to choose one of the planets in the solar system and use the internet, books and any other resource to find out as much as you can about that particular planet. You should then. Make this as fun as possible. Remember you are trying to attract them to the planet so that they take their holiday there! Other proj...

akampictures.com

AKAM PICTURES - Wedding Cinematography

akampion.com

:: akampion :: we create visibility

Please click here to subscribe to regular news updates from the akampioneer.com. Tuesday, May 12, 2015. Company News: New Peer-Reviewed Publication Provides Further Insights into Mechanism of ISA Pharmaceuticals’ SLP Immunotherapeutics. SLP s modulate intratumoral macrophages required for tumor regression. ISA Pharmaceuticals B.V. Monday, May 11, 2015. Company News: Curetis Strengthens Executive Team; Appoints Dr. Achim Plum as Chief Commercial Officer. A developer of next-level molecular diagnostic solu...

akampioneer.com

the akampioneer - news and opinions on innovation

Company News: New Peer-Reviewed Publication Provides Further Insights into Mechanism of ISA Pharmaceuticals’ SLP Immunotherapeutics. Tuesday, May 12, 2015. SLP s modulate intratumoral macrophages required for tumor regression. ISA Pharmaceuticals B.V. A clinical-stage immunotherapy company focusing on rationally designed immunotherapeutics against cancer and persistent viral infections, today announced the publication of a new peer-reviewed paper*. Posted in Company News. Monday, May 11, 2015. A develope...

akampita.com

Akampita | Connecting Mind, Body and Soul

Akampita is a MQA. Approved training centre which provides an array of tailor made training programs addressing the short and long terms requirements of the local industries. Akampita Yoga Weekend Retreat in Mauritius Program. Know before you go. Blog, News & Events. The 'Curing through Yoga Retreat program' was an excellent initiative to discover the wonders of Yoga within few lessons. Is a MQA approved training centre designed to address new skills gaps in the corporate world. Latest News and Events.

akampitasteiner.de

°°° Akampita Steiner - eine Ausnahme-Künstlerin °°°

Töne durch Seele bewegt. Seele in Worte gelegt. Körper durch Seele, Töne und Worte gelebt. Obertongesang, Konzertgitarre, Chanson, Improvisation,. Rezitation, Flöten, Monochord, Lyrik.

akampo.com

『祥仁漢方薬店』正規品は保証します!

今月 0401-04.30 当店で買い物すれば、風油精スイセン 6ml 1本をお客様にプレゼントいたします。携帯URL http:/ www.okampo.com/i/.

akampot.com

А кампот? Субъективный ресторанный блог гастрономической путешественницы

Рекомендационный субъективный (и полезный) ресторанный блог гастрономической путешественницы (и ее друзей;). Список мест по городам. Когда вы путешествуете, вы же, наверное, хотите кушать только в проверенных, рекомендованных и хороших местах? Блог вам в помощь, друзья! Коммерческий директор 1 1 media group. 16 мая, 23:00, Алгавре. Остров Самуи. Район Чавенг. Глава организации БФ "Центр допомоги". Group CEO of Havas Worldwide Ukraine. 15 мая, 10:00, Самуй. Must Be рестораны Лос Анджелеса, часть вторая:.